FDA approves ipilimumab for metastatic melanoma treatment
Links shared publicly online about this topic.
- 407total visits
FDA approves ipilimumab for metastatic melanoma treatment
View full resource at news-medical.net
Tags: Skin, Cancer, Skin Cancer, Melanoma, Diet and Nutrition, Drug, FDA
Most Recently Shared on March 28, 2011 at 9:34 am By:
Prostate Cancer: FDA approves ipilimumab for metastatic melanoma treatment: The U.S. Food and Drug Administratio... http://bit.ly/eJpGnS
Also Shared By:
Melanoma Research Alliance
curemelanoma.org — “Melanoma Research Alliance” View full resource at curemelanoma.org
Most Recently Shared on September 8, 2011 at 2:10 pm By:
Melanoma Research Oncology, Dermatology, and Health Organization
2 date MRA has awarded ovr $30 million to 73 research programs to help advance the prevention & treatment of #melanoma http://t.co/HM1Gt3F
Zelboraf approved for melanoma - - ModernMedicine
modernmedicine.com — “The Food and Drug Administration (FDA) has approved the oral targeted therapy vemurafenib (Zelboraf, Plexxikon/Roche) for treatment of metastatic and unresectable melanomas, Medscape Today reports.” View full resource at modernmedicine.com
Most Recently Shared on August 26, 2011 at 7:00 pm By:
Melanoma Research Oncology, Dermatology, and Health Organization
#Zelboraf is designed for patients w/ tumors that have a mutation in a BRAF gene that allows #melanoma cells to grow. http://t.co/mA0DCCc
Zelboraf approved for melanoma - - DermatologyTimes
dermatologytimes.modernmedicine.com — “The Food and Drug Administration (FDA) has approved the oral targeted therapy vemurafenib (Zelboraf, Plexxikon/Roche) for treatment of metastatic and unresectable melanomas, Medscape Today reports.” View full resource at dermatologytimes.modernmedicine.com
Most Recently Shared on August 24, 2011 at 7:12 pm By:
Dr.Amy & Dr.Gervaise Doctor, Dermatologist, and Physician
NEWS:FDA approved oral therapy Zelboraf, for treatment of metastatic & unresectable melanomas. Read Dermatology Times http://ow.ly/6bQYX
FDA Clears Roche's Drug
zacks.com — “FDA Clears Roche's Drug-Roche Holdings Ltd. recently received approval from the US Food and Administration for its drug - Zelboraf for the treatment of BRAF V600E mutation-positive, inoperable or metastatic melanoma.” View full resource at zacks.com
Most Recently Shared on August 19, 2011 at 11:54 pm By:
Zelboraf Approved for Late-Stage Melanoma
webmd.com — “The FDA today approved Zelboraf (vemurafenib) for the treatment of advanced or metastatic melanoma. The drug extends survival for the 50% of melanoma patients whose tumors carry the BRAF mutation.” View full resource at webmd.com
Most Recently Shared on August 18, 2011 at 6:30 pm By:
Zelboraf Approved for Late-Stage Melanoma http://t.co/n8sLYE6
Roche receives FDA approval for Zelboraf to treat BRAF mutation-positive metastatic melanoma
news-medical.net — “Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) approved Zelboraf (vemurafenib) for the treatment of BRAF V600E mutation-positive, inoperable or metastatic melanoma, as determined by an FDA-approved test.” View full resource at news-medical.net
Most Recently Shared on August 18, 2011 at 4:53 am By:
Roche receives FDA approval for Zelboraf to treat BRAF mutation-positive metastatic melanoma: Genentech, a membe... http://t.co/F1vr8IE
FDA Approves Skin Cancer Drug Zelboraf - ABC News
abcnews.go.com — “The U.S. Food and Drug Administration today approved the second late-stage melanoma drug this year, adding the drug to the treatment arsenal for patients with one of the deadliest forms of skin cancer. The drug, known as Zelboraf, could offer hope for patients with metastatic melanoma that cannot be removed with surgery, many experts said.” View full resource at abcnews.go.com
Most Recently Shared on August 18, 2011 at 2:52 am By:
Susan Scroggins Active Health Library and Health Advocate
FDA Approves Skin Cancer Drug Zelboraf: The U.S. Food and Drug Administration today approved the second late-sta... http://t.co/UPDCEEO
FDA Approves Skin Cancer Drug Zelboraf - ABC News
abcnews.go.com — “The U.S. Food and Drug Administration today approved the second late-stage melanoma drug this year, adding the drug to the treatment arsenal for patients with one of the deadliest forms of skin cancer. The drug, known as Zelboraf, could offer hope for patients with metastatic melanoma that cannot be removed with surgery, many experts said.” View full resource at abcnews.go.com
Most Recently Shared on August 18, 2011 at 12:20 am By:
FDA Approves Skin Cancer Drug Zelboraf: The U.S. Food and Drug Administration today approved the second late-st... http://t.co/Bud3Tnv
Vemurafenib Receives Approval for Metastatic Melanoma
onclive.com — “The FDA approved vemurafenib and a companion diagnostic test in a move that was hailed as an advance for both patients and personalized medicine.” View full resource at onclive.com
Most Recently Shared on August 17, 2011 at 9:44 pm By:
Vemurafenib Receives Approval for Metastatic Melanoma http://t.co/nu4DP7E
FDA Approval of Zelboraf Could Mean New Hope for Late-Stage Melanoma Patients | Skin & Aging
skinandaging.com — “FDA Approval of Zelboraf Could Mean New Hope for Late-Stage Melanoma Patients | Skin & Aging” View full resource at skinandaging.com
Most Recently Shared on August 17, 2011 at 8:16 pm By:
Skin & Aging Dermatology and Medical Journal
The FDA approved Zelboraf today, a BRAF inhibitor for the treatment of metastatic melanoma. Though a clinical... http://t.co/MKJ8s4h
Medical News: FDA OKs Late-Stage Melanoma Drug - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved vemurafenib (Zelboraf) for the treatment of metastatic and unresectable melanoma along with a companion genetic mutation test.” View full resource at medpagetoday.com
Most Recently Shared on August 17, 2011 at 8:08 pm By:
Michael A. Zadeh, M.D. Physician, Doctor, and Surgeon
FDA OKs Late-Stage Melanoma Drug http://t.co/3fgFcJl #medicine #health #cancer
FDA Approves Roche Companion Diagnostic for BRAF Mutation-Positive Melanoma | IVD Technology
ivdtechnology.com — “Roche announced that FDA approved Zelboraf (vemurafenib) for the treatment of BRAF V600E mutation-positive, inoperable or metastatic melanoma, as determined by an FDA-approved test. The FDA also approved the cobas 4800 BRAF V600 Mutation Test, a diagnostic test developed by Roche to identify patients eligible for treatment.” View full resource at ivdtechnology.com
Most Recently Shared on August 17, 2011 at 5:39 pm By:
IVD Technology Health Magazine
FDA Approves Roche Companion Diagnostic for BRAF Mutation-Positive Melanoma http://t.co/eRFc4Zl
Zelboraf and Companion Diagnostic Test Approved for Metastatic Skin Cancer - MPR
empr.com — “The FDA has approved Zelboraf (vemurafenib tablets; Genentech and Plexxikon) for the treatment of metastatic or unresectable melanoma in patients whose tumors express the BRAF V600E gene mutation.” View full resource at empr.com
Most Recently Shared on August 17, 2011 at 3:23 pm By:
FDA Approves Zelboraf, Improves Overall Survival in Metastatic Skin Cancer http://ow.ly/65whc #skincancer #melanoma
Whither Ipilimumab/Yervoy?
themelanomacenter.com — “When BMS announced that a second randomized prospective trial testing Ipilimumab in the frontline treatment of metastatic (Stage IV) melanoma was positive for increased overall survival, FDA approval for the novel drug seemed almost pre-ordained and inevitable. True, many felt [...]” View full resource at themelanomacenter.com
Most Recently Shared on June 1, 2011 at 4:30 am By:
Eric D Whitman, MD Doctor, Surgeon, Oncologist, and Physician
#ASCO2011 is just around the corner; newest post at TheMelanomaCenter.com, about the future of Yervoy, is up: http://bit.ly/kbSpUr
Vemurafenib New Drug Application Submitted To FDA For Melanoma
medicalnewstoday.com — “Daiichi Sankyo announced that applications have been submitted for market approval for vemurafenib (PLX4032/RG7204) for the treatment of metastatic melanoma to the U.S. Food and Drug Administratio” View full resource at medicalnewstoday.com
Most Recently Shared on May 13, 2011 at 7:05 am By:
MNT Pharma News Health News and Pharma
Vemurafenib New Drug Application Submitted To FDA For Melanoma http://mnt.to/3VNz #pharma #pharmaceutical
Advertisement
News-Medical.Net
@NewsMedical
Roche receives FDA approval for Zelboraf to treat BRAF mutation-positive metastatic melanoma: Genentech, a membe... http://t.co/F1vr8IE
1 year ago...